MARKET

GILD

GILD

Gilead Sciences Inc
NASDAQ
98.40
+1.83
+1.90%
Opening 09:44 11/11 EST
OPEN
96.42
PREV CLOSE
96.57
HIGH
98.53
LOW
96.30
VOLUME
828.95K
TURNOVER
--
52 WEEK HIGH
98.53
52 WEEK LOW
60.75
MARKET CAP
122.60B
P/E (TTM)
1171.37
1D
5D
1M
3M
1Y
5Y
1D
14 out of 18 healthcare companies beat profit estimates this week- Earnings scorecard
Seeking Alpha · 1d ago
Gilead Sciences: Finally Some Real Momentum
Seeking Alpha · 2d ago
Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
Benzinga · 2d ago
Aurinia Pharmaceuticals: A Potential Buyout Looms On The Horizon
Seeking Alpha · 2d ago
Gilead Sciences Cut to Hold From Buy by Maxim Group
Dow Jones · 2d ago
Validea Detailed Fundamental Analysis - GILD
NASDAQ · 2d ago
Maxim Group Downgrades Gilead Sciences to Hold
Benzinga · 2d ago
Gilead price target raised to $95 from $85 at TD Cowen
TipRanks · 2d ago
More
About GILD
Gilead Sciences, Inc. is a biopharmaceutical company. It is engaged in advancing medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis, coronavirus disease 2019 (COVID-19) and cancer. It is focused on the discovery, development and commercialization of medicines in areas of unmet medical need. Its portfolio of marketed products includes AmBisome, Atripla, Biktarvy, Cayston, Complera, Descovy, Descovy for PrEP, Emtriva, Epclusa, Eviplera, Genvoya, Harvoni, Hepcludex, Hepsera, Jyseleca, Letairis, Odefsey, Sovaldi, Stribild, Sunlenca, Tecartus, Trodelvy, Truvada, Truvada for PrEP, Tybost, Veklury, Vemlidy, Viread, Vosevi, Yescarta and Zydelig. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, and Domvanalimab and zimberelimab, and seladelpar. Seladelpar shall be used for the treatment of primary biliary cholangitis (PBC), including pruritus. The Company operates in more than 35 countries.

Webull offers Gilead Sciences, Inc. stock information, including NASDAQ: GILD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GILD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GILD stock methods without spending real money on the virtual paper trading platform.